|
|
|
July 24, 2007
TranS1 Files for IPO of Up To $80.5 Million
TranS1, Inc. is a medical device company focused on developing innovative, minimally invasive surgical procedures for treatment of low back pain. A percutaneous access and fusion system enables lumbar fusion to be performed with complete preservation of the annulus and all paraspinal soft tissue structures. TranS1 has now filed for an initial public offering. Read more here.
--------------------------------
Back to News
|
|
| |
